1. Cell-Penetrating And Antibacterial BUF-II Nanobioconjugates: Enhanced Potency Via Immobilization On Polyetheramine-Modified Magnetite Nanoparticles
- Author
-
Perez J, Cifuentes J, Cuellar M, Suarez-Arnedo A, Cruz JC, and Muñoz-Camargo C
- Subjects
Buforin-II conjugates ,drug delivery ,translocation ,Cell-penetrating peptides ,nanomaterials ,Medicine (General) ,R5-920 - Abstract
Jessica Perez, Javier Cifuentes, Monica Cuellar, Alejandra Suarez-Arnedo, Juan C Cruz, Carolina Muñoz-Camargo GINIB Research Group, Department of Biomedical Engineering, Universidad de los Andes, Bogotá, ColombiaCorrespondence: Carolina Muñoz-Camargo; Juan C Cruz Tel +57-1 3394949 Ext. 1789, 1853Email c.munoz2016@uniandes.edu.co; jc.cruz@uniandes.edu.coIntroduction: Controlled delivery of therapeutic molecules in a localized manner has become an area of interest due to its potential to reduce drug exposure to healthy tissues and consequently to minimize undesirable side effects. We have recently introduced novel cell-penetrating vehicles by immobilizing the antimicrobial peptide Buforin II (BUF-II) on magnetite nanoparticles (MPNPs). Despite the potent translocating abilities of such nanobioconjugates, they failed to preserve the antimicrobial activity of native BUF-II. In this work, we explored immobilization on MNPs with the aid of polymer surface spacers, which has been considered as an attractive alternative for the highly efficient conjugation of various biomolecules.Methods: Here, we immobilized BUF-II on polyetheramine-modified magnetite nanoparticles to preserve its structural integrity. As a result, for the obtained nanobioconjugates the lost antimicrobial activity against gram-positive and gram-negative bacteria was only 50% with respect to the native BUF-II. The nanobioconjugates were also characterized via FTIR, DLS, TEM, and TGA. Delivery on THP-1, HaCaT, HFF, and Escherichia coli cells was conducted to confirm capability for cell membrane translocation.Results: Colocalization with Lysotracker showed an endosomal escape efficiency of about 73∓12% in THP-1 cells. Avoidance of endocytic pathways of internalization was qualitatively confirmed by a delivery assay at low temperature. Nuclear penetration of the nanobioconjugates was corroborated via confocal microscopy and showed high biocompatibility as demonstrated by hemolysis levels below 5% and acute cytotoxicity of around 15%.Conclusion: The obtained nanobioconjugates were capable of translocating the cell membrane and nuclei of different normal and cancerous cell lines without significantly decreasing viability. This makes the vehicle addressable for a number of applications ranging from antimicrobial topical treatments to the delivery of nucleotides and therapeutic molecules with difficulties to bypass cell membranes.Keywords: Buforin-II conjugates, drug delivery, translocation, cell-penetrating peptides, nanomaterials
- Published
- 2019